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Abstract
Background: Investigators recently tested the effectiveness of a collaborative-care intervention for anxiety
disorders: Coordinated Anxiety Learning and Management(CALM) []) in 17 primary care clinics around the United
States. Investigators also conducted a qualitative process evaluation. Key research questions were as follows: (1)
What were the facilitators/barriers to implementing CALM? (2) What were the facilitators/barriers to sustaining
CALM after the study was completed?
Methods: Key informant interviews were conducted with 47 clinic staff members (18 primary care providers, 13
nurses, 8 clinic administrators, and 8 clinic staff) and 14 study-trained anxiety clinical specialists (ACSs) who
coordinated the collaborative care and provided cognitive behavioral therapy. The interviews were semistructured
and conducted by phone. Data were content analyzed with line-by-line analyses leading to the development and
refinement of themes.
Results: Similar themes emerged across stakeholders. Important facilitators to implementation included the
perception of “low burden” to implement, provider satisfaction with the intervention, and frequent provider
interaction with ACSs. Barriers to implementation included variable provider interest in mental health, high rates of
part-time providers in clinics, and high social stressors of lower socioeconomic-status patients interfering with
adherence. Key sustainability facilitators were if a clinic had already incorporated collaborative care for another
disorder and presence of onsite mental health staff. The main barrier to sustainability was funding for the ACS.
Conclusions: The CALM intervention was relatively easy to incorporate during the effectiveness trial, and
satisfaction was generally high. Numerous implementation and sustainability barriers could limit the reach and
impact of widespread adoption. Findings should be interpreted with the knowledge that the ACSs in this study
were provided and trained by the study. Future research should explore uptake of CALM and similar interventions
without the aid of an effectiveness trial.
Background
A n x i e t yd i s o r d e r sa r eh i g h l yp r e v a l e n t .I nt h eU n i t e d
States, population surveys estimate that close to 29%
have experienced an anxiety disorder in their lifetime
[1], while about 18% experience an anxiety disorder
each year [2]. Individuals with anxiety disorders suffer
significant impairment and reduced quality of life [3-5],
and they are costly to healthcare systems and economies
in general due to high use of healthcare and reduced
productivity [6-8]. Despite the high prevalence and
disease burden, only about one-third of persons with
anxiety disorders receive treatment in a given year [9].
Most of the treatment sought for anxiety is in primary
care, and the most frequent treatment is medication
[3,9]. While treatment guidelines recommend selective
serotonin reuptake inhibitor medication and cognitive
behavioral therapy (CBT) as first-line treatments [10,11],
CBT is under-utilized among anxiety patients [3], and
the quality of medication provided is suboptimal [9,12].
As primary care is the most frequent care location for
patients with anxiety, it is not surprising that clinical
research has focused on interventions for that setting.
Many of the empirically supported interventions to date
can be characterized as “collaborative care,” as they
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any medium, provided the original work is properly cited.center around the activities of a care manager, usually a
nurse or social worker, who maintains relatively fre-
quent contact with the patient; performs a range of psy-
choeducational, therapeutic, and monitoring functions;
and works as a liaison between the primary care provi-
der and a consulting mental health professional, usually
a psychiatrist. While most of the research and imple-
mentation work in the field thus far has concerned itself
with collaborative care for depression [13-15], a growing
literature supports collaborative-care interventions for
panic disorder [16,17] and for both panic disorder and
generalized anxiety disorder [18]. Authors of the current
manuscript [19] conducted a large randomized con-
trolled trial of a collaborative-care intervention in 17
community primary clinics for four anxiety disorders
(generalized anxiety disorder, panic disorder, posttrau-
matic stress disorder, and/or social anxiety disorder)
and recently published data showing it is effective, with
small to medium effects sizes,i nc o m p a r i s o nt ot r e a t -
ment as usual [20].
Given the effectiveness of these interventions, a next
generation of work will likely pursue implementation
research and the development and testing of implemen-
tation interventions and strategies to support wide-
spread adoption of collaborative care for anxiety
disorders. This work will draw upon current models of
implementation (e.g., Greenhalgh et al., 2004; Fixsen,
2005) [21,22] and the current implementation research
supporting current “roll-out” efforts for collaborative
c a r ef o rd e p r e s s i o n( a n do t h e rc h r o n i cc o n d i t i o n s )i n
large/national healthcare systems (e.g., the Department
of Veterans Affairs in the United States [15,23] and sev-
eral countries in Europe [24]). However, the anxiety-
specific collaborative-care interventions might have
unique features and could present their own barriers
and facilitators to translation into routine care, whether
they are adopted on their own or in conjunction with
other collaborative-care interventions for other mental
health disorders such as depression or alcohol use dis-
orders. To date, no implementation trials have been
conducted for anxiety collaborative-care interventions,
and little is known about the presence or absence of
specific barriers and facilitators to implementing and
sustaining such an intervention.
The purpose of this paper is to present qualitative
data from a process evaluation of the Coordinated Anxi-
ety Learning and Management (CALM) intervention, as
part of a randomized controlled effectiveness trial of a
collaborative-care for anxiety disorders. As noted above,
results from this study have been recently published
demonstrating CALM’s clinical effectiveness [20].
Alongside the effectiveness trial, investigators conducted
a qualitative process evaluation focused on the imple-
mentation of the CALM intervention in the
participating clinics. In the field of implementation
science, qualitative methods are frequently used to
improve understanding of healthcare contexts and to
shed light on key implementation challenges [25-27].
These methods are commonly part of what Stetler et al.
[28] refer to as “developmental formative evaluation”,
that is, context-specific “diagnostic” evaluation of bar-
riers and facilitators to implementation, which leverages
the experiences and lessons learned in effectiveness
trials to enhance the development of wider implementa-
tion and dissemination interventions. The qualitative
study described here is just such a developmental for-
mative evaluation. The key research questions were as
follows: (1) What were the facilitators/barriers to imple-
menting CALM? (2) What were the facilitators/barriers
to sustaining CALM after the study was completed?
It should be noted here that the study investigated
implementation of the CALM intervention during a
clinical effectiveness trial-the clinics were not explicitly
attempting to adopt the CALM intervention as part of
their routine care. The collaborative-care intervention-
ists were employees of the research study (though some
were previously employed by these same clinics), and
the providers were referring to them within the context
of a research study. However, many of the challenges
and successes associated with implementing research
interventions within community clinics are illustrative
and informative to future implementation efforts
[29,30]. Further, in the current study, the investigators
asked questions regarding the prospects of retaining the
intervention after the research grant was completed, and
t h o s ed a t aa r ed i r e c t l ya p p l i c a b l et ot h ei s s u eo f
sustainability.
Methods
Context of the process evaluation: The CALM
effectiveness study
A total of 1004 adult primary care patients with one of
four anxiety disorders (generalized anxiety disorder,
panic disorder, posttraumatic stress disorder, or social
anxiety disorder) were recru i t e df r o m1 7c l i n i c sw i t h i n
four national sites (Seattle, Los Angeles, San Diego, and
Little Rock). The clinics were purposively selected based
on a number of considerations, including clinician inter-
est, space availability, size and diversity of patient popu-
lation, and insurance mix. Anxiety clinical specialists
(ACSs) delivered education, self-activation in the context
of promoting medication adherence, and CBT to inter-
vention patients and monitored their symptoms using a
web-based system in which they recorded anxiety and
depression ratings at each contact. Intervention patients
chose CBT (34%), anti-anxiety medications (9%), or
both (57%) in a “stepped care” treatment that varied
according to clinical need. ACSs were located on-site in
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assistance of a computerized program. ACSs interacted
with an off-site study psychiatrist as needed and com-
municated clinical recommendations about medications
between the study psychiatrist and the patients’ primary
care providers. Control patients received usual care
from their primary care clinician. Anxiety symptoms,
functioning, satisfaction with care, and healthcare utili-
zation were assessed at six-month intervals. The salaries
of the ACSs were covered by the study, and most facil-
ities received some additional assistance/incentives, such
as fees, to cover the use of space and/or small amounts
of salary coverage for clinic liaisons/champions who
helped facilitate the study.
CALM’s innovations included (1) the flexibility to
treat any one of four anxiety disorders, co-occurring
depression, and/or alcohol abuse; (2) using on-site clini-
cians (ACSs) to conduct initial assessments; (3) a com-
puter-assisted psychotherapy delivery system; and (4) a
web-based system customized for anxiety status track-
ing. CALM was designed for easy dissemination in a
variety of primary care settings.
Study locations
The 17 clinics can be categorized as members of large
health maintenance organizations (HMOs; n = 4), feder-
ally qualified community healthcare centers (n = 4), uni-
versity-affiliated clinics (n = 4), or private clinics, either
free-standing or part of a hospital group (n = 5). Some
of the private clinics and federally qualified centers,
however, had university affiliations to some extent,
though they were not located on university campuses.
About two-thirds of the clinics were internal medicine,
with the remaining being family practice. Less than half
of the clinics had an in-house mental health provider or
providers, and those professionals were usually master’s-
trained clinicians (e.g., social workers, counseling psy-
chologists). About three-fourths of the clinics served
some uninsured patients.
Participants
The total number of participants in this qualitative key-
informant interview study was 61, including 14 ACSs
hired and trained by the study to conduct the interven-
tion, 18 primary care physicians (PCPs), 13 primary care
nurses, and 16 primary care clinic administrators or
other staff members. The ACSs came from nursing or
social work backgrounds almost exclusively, and all but
two were female. Eleven of the PCPs were internal med-
icine physicians, and the remaining seven were family
practice physicians. Twelve of the physicians were
female, and six were male. The clinic nurses were a rela-
tively even mixture of registered nurses, licensed practi-
cal nurses, and licensed vocational nurses. All but two
were female. The clinic administrators interviewed (n =
8) were the administrative leads for their clinics, and all
but three were female. The other “clinic staff” infor-
mants were a mixture of front desk clerks, scheduling
and administrative assistants, and project coordinators.
All but one was female. No other personal or demo-
graphic information was collected from the participants.
While a substantial majority of the participants were
female, we feel that the sample generally reflects the
characteristics of the work environment and the gender
make-up of the majority of the professions sampled,
namely, nursing, clinic administration, and social work.
In terms of recruitment, all of the ACSs were asked to
participate in the key informant interviews. Most of the
ACSs (N = 9) were interviewed twice, at a midpoint of
the intervention’s implementation and at the conclusion
of the study. Four ACSs were interviewed only at the
midpoint (two had moved on to another position by the
endpoint of the study). One was interviewed only at the
conclusion. Two ACSs refused to participate. The
majority of ACSs worked in one clinic at their respective
sites, but several worked in more than one (part-time)
across the span of the study. The PCPs, nurses, and
clinic administrators/staff with moderate-to-strong
involvement in the CALM study (as rated by the study
coordinators and/or ACSs) were targeted and “over-
sampled” for participation. The rationale for this was
that because the aim of the qualitative implementation
study was to uncover barriers and facilitators to imple-
mentation and sustainability of the intervention, it was
necessary to interview mostly those clinicians and staff
with at least moderate knowledge about the implemen-
tation, firsthand, in their clinics. However, clinicians and
staff less involved with the CALM intervention (approxi-
mately 20% of the sample) were also interviewed to pro-
vide balance. The implications of this sampling strategy,
both positive and negative, are discussed later in the
manuscript. The clinician and staff participants were all
interviewed during the final year of the intervention. We
did not track approaches to and refusal rates of clini-
cians and other staff. Some of the potential participants
were approached individually, based on their level of
participation with the CALM intervention, while others
were collectively approached in open calls for participa-
tion in meetings or via email. We did not predefine a
desired number of participants per category or site;
however, we attempted to get at least two employees
per clinic to participate, including at least one clinician.
Data collection
The study protocol, consent forms, and interview guides
were reviewed and approved by the Institutional Review
Boards at the University of Washington, the University
of California at Los Angeles, the University of California
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cal Sciences. After the study was described to potential
participants, written informed consent was obtained.
Data were collected via key informant interviews by
phone. Interview guides were used for each provider/
staff group, including ACSs. While each guide elicited
some information specific to the provider/staff type, a
common core of questions was included in all of the
interview guides (see Table 1). The questions were
decided upon by the study investigators collectively, and
the team revised them several times, including after the
interviews began.
T h el e a da u t h o ri n t e r v i e w e dt h eA C Ss a m p l ea tt h e
study’s close. One trained interviewer per host site
(Seattle, Los Angeles, San Diego, and Little Rock) inter-
viewed their clinic’s clinicians and staff. Interviews were
recorded and transcribed verbatim. In two instances, the
audio recorder malfunctioned and notes from the inter-
viewer were used during coding.
Data analyses
Transcripts were content analyzed through a combina-
tion of manual coding of printed transcripts and electro-
nic coding using ATLAS.ti software (ATLAS.ti Scientific
Software Development GmBH, Berlin, Germany). Con-
tent analysis is a common research method for the sub-
jective interpretation of text through a systematic
process of classifying text into categories or themes that
represent similar meanings [31]. In the current study,
the interview protocol was designed to support both
“conventional” and inductive and “directed” ap r i o r i
content analyses [32,33]. The protocol included a mix-
ture of “grand-tour” type questions that are common
opening questions for inductive analyses (e.g., “Tell me
about your role and involvement in the CALM project”
and “How was CALM implemented in your clinic and
how did it go?”) and more specific questions/probes
informed by existing conceptual models of
implementation [21,34], which focused on the organiza-
tional context (norms and attitudes, routine care proce-
dure, resources), the process of implementation (stage of
adoption, variation in implementation), and mechanisms
of diffusion (influence of peers/leaders, change agents,
incentives). With conventional content analyses, investi-
gators focus on descriptions of phenomena to identify
themes and concepts that emerge from reading the
interview transcript text without being constricted to a
specific theory or conceptual model of behavior (i.e.,
keeping an open-as opposed to an empty-mind). With
directed content analysis, investigators are guided by
existing theory or research findings and explore prede-
termined themes or concepts in their coding. We
employed both types of content analysis, with an
emphasis on the former.
In terms of coding, the lead author coded the ACS
interviews himself, while he and another investigator co-
coded the provider/staff interviews. When two coders
were involved, they independently coded identical sec-
tions of text and compared coding and interpretations.
Each subsample of participants’ transcripts was coded as
a group, in this sequence: ACSs, physicians, nurses,
administrators, and staff. This method allowed the
coders to focus on that data and emergent themes of
one group at a time (as opposed to coding random tran-
scripts), and the sequence allowed the coders to investi-
gate the stakeholders most involved with the CALM
intervention first (ACSs), then in descending order of
overall stakeholder involvement in implementation.
Informed by the aims of the study and guided by pre-
v i o u se x a m p l e so fs i m i l a rimplementation analyses
[25-27], the transcripts were first coded using the “top-
level” codes (or “macro-themes”)o fbarriers/facilitators
to implementation and barriers/facilitators to sustain-
ability. Organizing the analyses around these top-level
codes [35] improved the “usability” of the information
and allowed the data to be blended easily with other
reports documenting implementation barriers/facilitators
for major mental health initiatives. Top-level codes were
used to broadly categorize the data and represent infor-
mants’ beliefs about which factors hindered or facilitated
implementation and/or sustainability of the CALM
intervention and how the intervention could be
improved. Further subcoding of categories within each
top-level code came next. The subcoding step assigned
new codes that described the content of the barriers/
facilitators reported by the participants (e.g., “provider
interest in mental health issues” as a facilitator of imple-
mentation). A third coding step classified the individu-
ally categorized barriers/facilitators into types, such as
“provider attitudes/behaviors as facilitators” and “clinic
structure-related barriers.” This last step was interpre-
tive, representing the views of the coders. The final list
Table 1 Core questions for all qualitative interviews
1. How did CALM operate in your clinic?
2. What worked and what didn’t work?
3. How did CALM affect workload, burden, and space?
4. How was CALM received by you and others in your site and how
did that change over time?
5. Were there “champions” or “opinion leaders” for CALM?
6. Did the communication between the ACS, the external psychiatrist,
and local PCPs work?
7. What outcomes are/were you seeing?
8. What changes should be made to CALM?
9. What are the prospects for CALM being sustained and why?
CALM = Coordinated Anxiety Learning and Management; ACS = anxiety
clinical specialist; PCP = primary care physician
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acteristics, contexts, processes, and policies the infor-
mants believed to be associated with the
implementation and sustainability of the CALM
intervention.
Results
While numerous barriers and facilitators were recog-
nized and reported by the informants, we chose to high-
light here those reported most often and those referred
to by the participants as the most salient from their per-
spective. Additional information about the full range of
barriers and facilitators is available from the authors.
Below we present barriers and facilitators to implemen-
tation and sustainability, across stakeholder and clinic
types, organized by the following subcategories: provider
attitudes/behavior, clinic structure, intervention charac-
teristics, and patient characteristics (See also Table 2).
Barriers/facilitators are noted in italicized text. Exemplar
quotations are contained in Additional file 1.
Barriers to implementation
Provider attitudes/behaviors
The most often cited barrier to implementation across
stakeholders was uneven physician “buy-in” or support
for the CALM intervention within clinics. A common
pattern emerged: some physicians were highly motivated
to participate in the intervention, some were marginally
so, and some were not at all motivated to participate.
The highly motivated physicians were usually less than
half of the total number of physicians in a clinic.
Further, participants across stakeholder groups recog-
nized that it was challenging to increase physician inter-
est. Many participants speculated that the less
enthusiastic physicians were not comfortable with treat-
ing mental health. Others noted that low enthusiasm
could also be linked to providers (both physicians and
nurses) feeling that the prevalence of anxiety was low in
their clinic. Also, many physicians reported that enthu-
siasm for the intervention could wane without supportive
attention from “champions” or “opinion leaders.”
Clinic structure
Two very commonly noted barriers to implementation
across stakeholder group and clinic types were high pre-
valence of part-time primary care providers and space
concerns for the ACS. The ACS and physician stake-
holder groups especially reported concerns about part-
time physicians (including residents) being harder to
reach with information about CALM than full-time pro-
viders, and thus it was harder to engage with them and
facilitate their involvement. University-affiliated clinics
with large numbers of residents seemed most impacted
by the barrier. Informants from all stakeholder groups
and clinic types noted barriers associated with finding
adequate space for the ACSs to do their work. If an
ACS’s work space was not proximal to the providers,
their relationships with them suffered. Further, if an
ACS had no permanent or reliable place to work, a
Table 2 Major Themes
Major Theme Subtheme
Barriers to
Implementation
Provider attitudes/
behaviors
Uneven physician “buy in”
Enthusiasm could wane without continued
intervention
Feeling that prevalence of anxiety was low in
their clinic
Clinic structure Part-time primary care providers harder to
reach
Space concerns for ACS
Intervention
characteristics
Part-time ACS
Communication with ACSs sometime
unsatisfactory
Some nurses felt “out of the loop” and not
consistent targets for education and
marketing
Patient characteristics Challenges of Low SES patients
Hispanic patients resistant to CALM
Drop-outs weaken enthusiasm among
providers and staff
Facilitators to
Implementation
Provider attitudes/
behaviors
Interest in mental health increases uptake
Buy-in/support from nurses/staff
Clinic structure Presence of MH professional
Reliable and appropriate space for ACS
Intervention
characteristics
ACS in clinic full time (or close)
“Face-time” with providers/relationships
CALM not overly burdensome
Providers appreciated referral source and
additional care
Positive feedback from/about patients
Providers very positive about ACS
Patient Characteristics Prefer coming to primary care
Barriers to Sustaining
CALM
Clinic structure Paying for ACS service
Space for ACS and doing therapy
Facilitators to
Sustaining CALM
-Provider attitudes Providers high value of CALM
-Clinic structure Already doing CC for other disorders
Presence of MH person who could adopt
MH = mental health; ACS = anxiety clinical specialist; PCP = primary care
physician; CALM = Coordinated Anxiety Learning and Management; SES =
socioeconomic status; CBT = cognitive behavioral therapy; CC = collaborative
care.
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munication with providers and negatively impacted
referrals.
Intervention characteristics
An often cited barrier to implementation within this
category was ACSs who worked part-time in a clinic.
Referrals are hindered when an ACS is on-site only cer-
tain days per week to receive them. Also, less “face time”
in the clinic means less communication and fewer oppor-
tunities for building rapport with clinic providers and
staff. Some physicians discussed communication with
ACSs being unsatisfactory. Interestingly, the nature of the
dissatisfaction was not uniform. In fact, some physicians
wanted more frequent and extensive communication
with the ACS, while others felt there was too much. A
goal of the CALM intervention was to customize com-
munications with providers to meet their requests/needs
for monitoring patients, and it appears that this was not
optimized during the study. In addition, some nurses
reported feeling “out of the loop” between their PCPs, the
ACSs, and the off-site psychiatrist, and they felt that they
could not act as “champions” for the intervention when
they were out of the loop. This barrier could also fall
under the category of clinic structure if its genesis had
more to do with pre-existing clinic culture. Some nurses
also reported only hearing about the intervention from
their PCP, indicating that in some clinics the nurses were
not consistent targets for education and marketing about
the intervention.
Patient characteristics
Some physicians noted that when patients drop out or “no
show” for their ACS appointments, this can weaken their
enthusiasm for the intervention. Perhaps related to this, a
patient-related barrier noted among ACSs working in
clinics with high numbers of uninsured was that the high
overall disease burden and social stressors among lower
socioeconomic status (SES) patients seemed to make it
harder for those patients to engage in the intervention.
The pressures of unstable employment, housing, and
transportation appeared to negatively affect how some
patients prioritized their anxiety treatment. Two ACSs
who worked in clinics that saw many Hispanic patients
noted that in general, Hispanic patients were reluctant to
engage in the CALM intervention. They speculated that
culturally bound beliefs about mental illness were contri-
buting to males being resistant to admitting a problem
and females not getting necessary support from their
families to participate in the sessions.
Facilitators to implementation
Provider attitudes/behaviors
Implementation seemed to go smoothly and referrals to
the ACS were most plentiful when physicians (espe-
cially) and nurses had enthusiastically “bought in” to the
intervention.T h ef a c t o rm o s tl i n k e dt os t r o n gb u y - i n
was a belief that mental health concerns should be a
priority. This is the inverse of the buy-in barrier noted
above. It is unclear to what extent education and out-
reach efforts of the study investigators and the ACSs
influenced this priority setting. When the ACSs were
asked to speculate on this point, they reported that
most of the enthusiastic providers were that way “from
the get go,” indicating that many providers were posi-
tively predisposed to a mental health intervention.
Approximately half of the providers interviewed self-
identified as champions of the intervention. Some ACSs
made the point that a highly “bought in” nurse could act
as a champion and facilitate numerous contacts and
referrals, even in the case where his/her physician was
not as enthusiastic. Informants from all of the stake-
holder groups noted that when positive outcomes of
patients were communicated, this increased provider
enthusiasm and referral activity. Additionally, when
reduced somatic complaints were observed in some
patients, provider enthusiasm increased.I na d d i t i o n ,
among those with a favorable view of CALM, providers
did not need to see dramatic improvements in their
patients to maintain a positive attitude towards the
intervention. As well, most provider informants said
they appreciated the additional referral source.
Clinic structure
Two related facilitators in this category were pre-existing
presence of a mental health provider and pre-existing
presence of collaborative-care services for another disor-
der. If the providers were in the habit of referring
patients to another mental health specialist within their
clinic, or were in the habit of using a collaborative-care
coordinator of some kind, those factors facilitated the
u s eo ft h eA C S .T h el a r g eH M Oc l i n i c sw e r et h em o s t
likely to be already employing a collaborative-care coor-
dinator for another disorder (e.g., diabetes commonly
and, in one case, depression). As noted above, the in-
house mental health professionals were usually master’s-
level clinicians. The interviews with the ACSs did not
uncover much information about their relationship with
these providers, though some found them to be “good
referrers.”
Intervention characteristics
Perhaps the most universal facilitator across clinic stake-
holders was that the CALM intervention was not overly
burdensome. The physicians and nurses reported little to
no increased burden in their workload, and many noted
reductions in their workload as a result of reduced
somatic complaints. The vast majority found the referral
processes very easy and that referrals worked best when
the ACSs were in the clinic full time. While it was usual
for providers to leave a paper-and-pencil or electronic
referral note for the ACSs to follow up on, some
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with the patient for a face-to-face “hand-off.” These
face-to-face hand-offs were certainly easier when the
ACSs were in the clinic full-time, but the other kinds of
referrals were also more quickly acted upon when the
ACS was in the clinic full-time. Further, the ACSs
found that the more they had “face time” with providers
to discuss CALM and establish rapport, the better the
implementation went. Face time could occur in the hall-
ways, at lunchtime, or during staff meetings. From the
clinic stakeholder point of view, when ACSs were seen
as warm, engaging, and visible, they received high
marks. And most of the informants who commented
specifically about their ACS did so very positively. Most
of the providers found the distribution of flyers and
information about the study in the patient rooms and/or
waiting rooms to be helpful, with this resulting in many
patients presenting their concerns about anxiety and
asking about the intervention without needing to be
screened or prompted.
Patient characteristics
The main patient-level facilitator seemed to be that
many expressed their preference to these informants
(especially the nurses) that they prefer coming to primary
care for their mental health issues. This preference
seemed to be rooted in both the ease of coming there
("one-stop shopping”) and that stigma was reduced by
coming to primary care and seeing a mental health pro-
vider there.
Barriers to sustainability
Clinic structure
The two main barriers expressed by the vast majority of
stakeholders were paying for the ACS services and space
for the ACS. Most, but not all, of the stakeholders
expressed doubt that the intervention would be main-
tained and that the main “culprit” would be the diffi-
culty in paying for the ACS. A payor or payors would
have to decide to reimburse for the services, an external
source would have to provide the service for free (e.g., a
university psychiatry department), or the clinic would
have to pay for the employee themselves. In the latter
case, the informants indicated that a strong “business
case” would have to be made in favor of it and that this
seemed unlikely at the present time. Further, many par-
ticipants noted their difficulty in finding appropriate
space for the ACS during the intervention, and they sus-
pected that this would continue if they tried to sustain
the intervention.
Facilitators to sustainability
Provider attitudes/behavior
Numerous providers and administrators reported a posi-
tive opinion about the CALM intervention and expressed
that they would like to see CALM continue in their
clinic. Many informants reported that, overall, the inter-
vention increased their clinic’s awareness of anxiety and
that increased their desire to continue treating anxiety.
Clinic structure
The clinics that already have a mental health provider
or a collaborative-care program for another disorder felt
more confident that sustaining CALM was possible or
even probable in a minority of cases.
Discussion
Overall results and key findings
This qualitative process evaluation found, in general, that
the CALM collaborative-care intervention for multiple
anxiety disorders was not overly burdensome to provi-
ders and staff, and it was relatively easy to incorporate
into the clinics’ routine. Satisfaction with the intervention
among these respondents was generally high. Primary
care providers appreciated the additional referral source
and the feedback they received from the ACS and psy-
chiatrist. The majority of informants reported seeing
moderate improvements in enough patients for them to
find value in the intervention. A majority of informants
stated, without being prompted, they would like to see
the intervention continue after the clinical effectiveness
study was over. We did not see much evidence of out-
right “resistance” to the CALM intervention, rather more
a lack of motivation/buy-in from a number of providers
and some not seeing it as solving key concerns of the
clinics, which served more as a challenge to sustainability
than uptake during the clinical trial.
There were many important facilitators to implemen-
tation, perhaps the most important being positive atti-
tudes about the intervention among providers (buy-in).
Providers who held a pre-existing belief in the impor-
tance of recognizing and treating mental health pro-
blems in primary care, who found the intervention
nonburdensome, who perceived the ACS as visible and
well-liked, who valued the feedback from the clinical
team, and who observed positive patient outcomes
(especially reduced somatic complaints) were those who
most enthusiastically supported the intervention. Other
facilitators were a reliable and proximate location of the
ACS’s workspace, having the ACS work full-time in the
clinic, “face time” for ACSs to interact frequently with
providers, and the perception of a relatively high preva-
lence of anxiety among clinic patients. Those clinics
with previous experience with an on-site mental health
provider and/or collaborative-care interventionist
appeared to more readily implement the intervention. It
is also possible that clinics with pre-existing mental
health providers attracted a greater number of patients
with anxiety disorders, and therefore, those clinics might
have recognized a greater benefit of the intervention.
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found. First and foremost, it was clear that not all provi-
ders bought in to the intervention. Some were infre-
quent users of the intervention, and some never used it
at all. For some, this relative lack of use appeared to be
tied to their impression that anxiety prevalence was low
in their clinics. For others, the lack of use appeared to
be linked to a general lack of comfort with treating
mental illness or a belief that mental health should not
be treated in primary care. Further, these providers did
not seem to respond to (or perhaps did not attend) tra-
ditional educational sessions by experts presenting evi-
dence on anxiety prevalence and effectiveness of
collaborative-care interventions. It is possible that addi-
tional marketing of the intervention might have
improved provider buy-in. However, many of the provi-
ders’ attitudes might have been relatively easily fixed.
Future research should test the effect of various market-
ing strategies in primary care clinics.
In addition, it was clear that nurses in some clinics
served as key advocates and sources of referral. Yet, the
study did not specifically market to clinic nurses or pro-
vide educational opportunities for them. This was an
important oversight. Future studies should consider
active promotion of primaryc a r ei n t e r v e n t i o n sw i t h
clinic nursing staff. Other key barriers to implementa-
tion were having large numbers of part-time primary
care providers within a clinic, using a part-time ACS, a
lack of dedicated space for ACSs, unsatisfactory commu-
nication with ACSs, and engagement challenges related
to low SES and Hispanic patients. Important barriers to
sustainability of the intervention were the cost of the
ACS (a “deal-breaking” barrier) and space concerns.
There were not many dramatic differences in reaction
to the intervention across stakeholder groups or clinic
types, but a few differences did emerge. Clinic adminis-
trators/managers, who were usually those charged with
finding ACS work space and overseeing clinic opera-
tions, reported the most initial skepticism about the
intervention and reported experiencing the most burden
caused by the intervention. The burden, however, was
still mild to moderate, and administrators were generally
quite positive about the intervention. In terms of clinic
types, the federally qualified community health centers
were perhaps at some disadvantage because more of
their patients were low SES, and those patients seemed
t os t r u g g l em o r ew i t he n g a g e m e n t .A tt h es a m et i m e ,
providers in these clinics seemed to especially appreciate
the additional referral source (a free mental health inter-
vention for their patients). Offering CBT was also a key
draw for participation as some of the providers reported
very little access to CBT, even when a patient was
insured. Two clinics administered by a large, regional
HMO and one university-affiliated clinic had experience
with collaborative-care interventions, and providers in
these clinics were more likely to think that sustainability
would be feasible.
Findings in context of the literature
Most of the barriers and facilitators found in this study
are consistent with leading conceptual models of disse-
mination and implementation in healthcare and the
empirical literatures supporting them. For example,
numerous barriers and facilitators to implementation
and sustainability reported by informants had to do with
provider beliefs, attitudes, motivation, and norms, and
these are central determinants of implementation in the
models of Mendel et al. [34], Greenhalgh et al. [21], and
Damschroder et al. [36]. These “personal” determinants
certainly interact with the characteristics of the innova-
tion. Most implementation models in healthcare place a
good deal of emphasis on predisposing characteristics of
the innovation for implementation success. For example,
Greenhalgh et al.’s [21] model, based on empirical find-
ings, posits that an innovation has a better chance of
successful adoption when it has demonstrated clinical
advantage (via research evidence), compatibility with
existing practices, observability (of results), low com-
plexity, and potential for local tailoring. These same
general attributes are also reflected in the diffusion and
implementation models of Rogers [37] and Damschro-
der et al. [36]. Innovation characteristics interact not
only with provider/staff-level attributes but also with
clinic-level attributes such as culture (norms and prac-
tices of the system) and climate (worker’s perceptions
of, and reaction to, the characteristics of the work envir-
onment) [38]. We found that if the clinic culture had
previous experience with collaborative care and/or mak-
ing internal referrals for mental health conditions, this
promoted both successful implementation and increased
the perception of sustainability. This study also identi-
fied barriers and facilitators associated with how the
intervention was supported “on the ground” by study
and clinic staff. Central to the Promoting Action on
ResearchImplementation in Health Services (PARIHS)
implementation framework is the notion of facilitation,
defined as “making things easier for others” [39]. This
model suggests that implementation success is maxi-
mized when there are coordinated efforts to encourage
participation, promote action, create supportive systems,
and monitor and feedback progress. This study suggests
that clinics in which ACSs operated not only as clini-
cians but also as facilitators in conjunction with local
champions were more successful. Lastly, this study
found the major barrier to sustainability to be financial
(i.e., paying for the key interventionist). Most implemen-
tation models recognize and emphasize the cost and
payor factor, along with others making up the “outer
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mate, mandates, and incentives) [21,34,36,40].
It was apparent from the analyses that at least two
“meta-themes” emerged-the first being associated with
communication. Many of the barriers and facilitators we
found appear related to positive communication among
the ACS, primary care staff, and study-provided psychia-
trist, for example, satisfaction with communication with
the ACS, nurses being in or out of “the loop,” positive
clinical outcomes being communicated to the providers,
ACSs being part-time or full-time, face-to-face hand-offs
of patients, and space (proximity to ACSs). These com-
munication issues are certainly linked to rapport and
trust, and together they form a necessary foundation for
a working collaborative relationship. It is clear from
these analyses that for a collaborative-care intervention
to be successfully implemented, there need to be posi-
tive lines of communication created that foster rapport
and trust. The second meta-theme relates to the lack of
anxiety-specific barriers and facilitators observed. Most
of the barriers and facilitators were similar to those
noted for depression collaborative care and perhaps
other collaborative-care interventions in other non-men-
tal health conditions [15,41]. The one anxiety-specific
barrier mentioned was a perceived low prevalence of
anxiety in some clinics. This could mean that interven-
t i o n ss u c ha sC A L Mf o ra n x i e t yd i s o r d e r sw o u l db e
amenable to being combined with other collaborative-
care interventions, at least for mental health conditions,
as seems to be the current thrust in some health sys-
tems [42]. Such combinations could be more cost effec-
tive and improve the “business case.” The CALM
intervention already combined multiple anxiety disor-
ders and had a companion module for comorbid
depression.
Implications and future directions
The next step in the research agenda for CALM investi-
gators will be to develop and test an implementation
strategy to facilitate adoption under more naturalistic
circumstances, that is, without research funding cover-
ing the ACS salaries and other cost offsets. This
research provides important data to inform the develop-
ment of such an implementation strategy. The data pre-
sented here indicate that the implementation strategy
should, at a minimum, include the following elements:
1) A marketing plan designed to engage those who
are not predisposed to identifying and treating men-
tal health problems in primary care [15] and
includes physicians, nurses, and administrators.
2) Encouragement of the clinic participants to tailor
the intervention to their needs [43], with special
attention paid to the process of communication
between providers and the collaborative-care team
(ACS and psychiatrist) and space for the ACSs.
Roles and responsibilities of champions and opinion
leaders should also be made explicit [27,44], with
some consideration given to training champions
and/or opinion leaders in evidence-based facilitation
strategies [44].
3) A process for delivering “easily digestible” out-
comes data elements to providers and staff to rein-
force uptake [45].
4) Additional features to support engagement of
lower SES patients Hispanic patients.
5) A focus on financing. Bachman and colleagues
[46] have outlined an array of possible funding
mechanisms for depression care management that
also apply to CALM, for example, practice-based
care management on a fee-for-service basis, practice-
based care management under contract to health
plans, group-model HMO internal funding, and
third-party-based care management under contract
to health plans. Any implementation strategy would
need to include efforts at securing “coverage” of the
ACS.
Study limitations and strengths
The study has several limitations that deserve mention.
As noted above, this study investigated barriers and
facilitators to the implementation of the CALM inter-
vention during a clinical effectiveness trial. The implica-
tions derived here, while contributing to accumulating
findings on collaborative-care interventions, still need to
be tested in future implementation trials and observa-
tional studies of real-world adoption in order to be gen-
eralizable. Further, the timings of the clinic provider and
staff interventions were not uniform. They occurred
during the final year of a two-year intervention. There-
fore, “exposure” to the intervention and its outcomes
varied considerably, and this difference could have
impacted the results. Perhaps most importantly, the
sampling strategy likely introduced a positive bias in
that most of the participants were at least moderate
users of CALM, and such users were more likely to be
positively predisposed to the intervention. The investiga-
tors decided that the majority of respondents should
have at least moderate experience with the intervention
to be able to provide the richest feedback. To counteract
this bias, we did interview providers and staff with less
or no direct involvement with the CALM intervention.
Also, the ACS interviews asked specific questions about
provider and staff buy-in from the perspective of the
clinic as a whole, which also contributed balance.
The study has several strengths that also deserve men-
tion. Very few clinical effectiveness studies devote the
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cess evaluation. By doing so, the investigators were able
to gather useful data to help them plan for future imple-
mentation efforts and reduce the time between develop-
ment of research findings and adoption in routine care
settings. Further, the process evaluation was large in
scope, encompassing 61 key informants from multiple
perspectives across 17 clinics. The use of semistructured
interview guides contributed consistency and reliability
to the data collection but did not limit the flow of con-
versation or discovery of themes. Also, “saturation” was
reached, indicating that the number of interviews per
stakeholder group was sufficient to fully explore the
phenomena under study.
Conclusions
This study demonstrated that the CALM intervention is
implementable in community settings within a clinical
research context and supported by appropriate facilita-
tion provided by research investigators and staff. Future
research will develop and test implementation
interventions.
Additional material
Additional file 1: Major themes and exemplar quotations from
informants.
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